Meinian Onehealth Hits Day Low of CNY 5.48 Amid Price Pressure

Meinian Onehealth Healthcare Holdings Co., Ltd. experienced a notable decline today, with the stock dropping by 3.78% and reaching an intraday low of CNY 5.48. This performance contrasts sharply with the China Shanghai Composite, which saw a modest decrease of 0.17% on the same day. Over the past week, Meinian Onehealth has faced a more significant downturn, with a 12.23% decline, while its one-year performance shows a return of 10.44%, lagging behind the broader market's 24.02% gain. The company's financial metrics reveal a challenging landscape, as it reported a pre-tax profit of CNY -278.08 million, marking a substantial fall of 316.01%. Additionally, net profit plummeted to CNY -249.87 million, a staggering decline of 479.44%. Despite being net-debt free, the company has struggled with long-term growth, evidenced by a net sales growth rate of only 9.49% over the past five years. With a market capitalization of CNY 23,863 million, Meinian Onehealth continues to navigate a complex financial environment within the pharmaceuticals and biotechnology sector.